精神科医療の普及と教育に対するガイドラインの効果に関する研究
~Effectiveness of GUIdeline for Dissemination and Education in psychiatric treatment~
学術論文
Yasui-Furukori N, Muraoka H, Hasegawa N, Ochi S, Numata S, Hori H, Hishimoto A, Onitsuka T, Ohi K, Hashimoto N, Nagasawa T, Takaesu Y,
Inagaki T, Tagata H, Tsuboi T, Kubota C, Furihata R, Iga J, Iida H, Miura K, Matsumoto J, Yamada H, Watanabe K, Inada K, Shimoda K,
*Hashimoto R. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a
nationwide dissemination and implementation study. Neuropsychopharmacology Reports, in press
DOI:10.1002/npr2.12218
Furihata R, Otsuki R, Hasegawa N, Tsuboi T, Numata S, Yasui-Furukori N, Kashiwagi H, Hori H, Ochi S, Muraoka H, Onitsuka T, Komatsu H,
Takeshima M, Hishimoto A, Nagasawa T, Takaesu Y, Nakamura T, Asami T, Miura K, Matsumoto J, Ohi K, Yasuda Y, Iida H, Ogasawara K,
Hashimoto N, Ichihashi K, Yamada H, Watanabe K, Inada K, *Hashimoto R. Hypnotic medication use among inpatients with schizophrenia and
major depressive disorder: results of a nationwide study. Sleep Med、89:23-30, 2021.12
DOI:10.1016/j.sleep.2021.11.005
Japanese Society of Neuropsychopharmacology. Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of
Schizophrenia". Neuropsychopharmacol Rep, 41(3):266-324, 2021.9
DOI:10.1002/npr2.12193
Hashimoto N,*Yasui-Furukori N, Hasegawa N, Ishikawa S, Numata S, Hori H, Iida H, Ichihashi K, Furihata R, Murata A, Tsuboi T,
Takeshima M, Kyou Y, Komatsu H, Kubota C, Ochi S, Takaesu Y, Usami M, Nagasawa T, Hishimoto A, Miura K, Matsumoto J, Ohi K, Yamada H,
Inada K, Watanabe K, Shimoda K, Hashimoto R. Characteristics of discharge prescriptions for patients with schizophrenia or major depressive
disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
Asian Journal of Psychiatry, 63:102744, 2021.7 DOI:10.1016/j.ajp.2021.102744 日本語の概要は こちら
Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J,
Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E,
Ohi K, Hishimoto A, Inada K, Watanabe K, *Hashimoto R. Improvements in the degree of understanding the treatment guidelines for
schizophrenia and major depressive disorder in a nationwide dissemination and implementation study. Neuropsychopharmacol Rep,
41(2):199-206, 2021.6 DOI:10.1002/npr2.12173 日本語の概要は
こちら
Iida H, Iga J, Hasegawa N, Yasuda Y, Yamamoto T, Miura K, Matsumoto J, Murata A,
Ogasawara K, Yamada H, Hori H, Ichihashi K, Hashimoto N, Ohi K, Yasui-Furukori N, Tsuboi T, Nakamura T, Usami M, Furihata R, Takaesu Y,
Iwamoto K, Sugiyama N, Kishimoto T, Tsujino N, Yamada H, Hishimoto A, Nemoto K, Atake K, Muraoka H, Katsumoto E, Oishi S, Inagaki T,
Ito F, Imamura Y, Kido M, Nagasawa T, Numata S, Ochi S, Iwata M, Yamamori H, Fujita J, Onitsuka T, Yamamura S, Makinodan M, Fujimoto M,
Takayanagi Y, Takezawa K, Komatsu H, Fukumoto K, Tamai S, Yamagata H, Kubota C, Horai T, Inada K, Watanabe K, Kawasaki H,
*Hashimoto R. Unmet need for major depressive disorders-Findings from the ‘Effectiveness of Guidelines for Dissemination
and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study. Psychiatry Clin
Neurosci,74(12):667-669, 2020.12 DOI:10.1111/pcn. 13143 日本語の概要は
こちら
Ichihashi K, Hori H, Hasegawa N, Yasuda Y, Yamamoto T, Tsuboi T, Iwamoto K, Kishimoto T, Horai T, Yamada H, Sugiyama N,
Nakamura T, Tsujino N, Nemoto K, Oishi S, Usami M, Katsumoto E, Yamamori H, Tomita H, Suwa T, Furihata R, Inagaki T, Fujita J, Onitsuka T,
Miura K, Matsumoto J, Ohi K, Matsui Y, Takaesu Y, Hashimoto N, Iga J, Ogasawara K, Yamada H, Watanabe K,
Inada K, *Hashimoto R. Prescription patterns in patients with schizophrenia in Japan: first-quality indicator data from the
survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project. Neuropsychopharmacol
Rep, 40(3):281-286, 2020.9 DOI:10.1002/npr2.12122 日本語の概要は
こちら →NPPR Article Award 2021を受賞しました。(詳細はこちら)
Takaesu Y, Watanabe K, Numata S, Iwata M, Kudo N, Oishi S, Takizawa T, Nemoto K, Yasuda Y, Tagata H, Tsuboi T, Tsujino N, Hashimoto N,
Matsui Y, Hori H, Yamamori H, Sugiyama N, Suwa T, Kishimoto T, Hishimoto A, Usami M, Furihata R, Iwamoto K, Fujishiro H, Nakamura T,
Mizuno K, Inagaki T, Katsumoto E, Tomita H, Ohi K, Muraoka H, Atake K, Iida H, Nagasawa T, Fujita J, Yamamura S, Onitsuka T, Murata A,
Takayanagi Y, Noda H, Matsumura Y, Takezawa K, Iga J, Ichihashi K, Ogasawara K, Yamada H, Inada K, *Hashimoto R.
Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the
“Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE) ” project: a nationwide dissemination,
education and evaluation study. Psychiatry Clin Neurosci, 73(10):642-648, 2019.10
DOI:10.1111/pcn.12911 プレスリリースの内容は
こちら